Medistim ASA
OSE:MEDI
Medistim ASA
PP&E Net
Medistim ASA
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medistim ASA
OSE:MEDI
|
PP&E Net
kr73.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
17%
|
|
|
Lifecare AS
OSE:LIFE
|
PP&E Net
kr9.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
Observe Medical ASA
OSE:OBSRV
|
PP&E Net
kr2m
|
CAGR 3-Years
41%
|
CAGR 5-Years
101%
|
CAGR 10-Years
N/A
|
|
Medistim ASA
Glance View
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.
See Also
What is Medistim ASA's PP&E Net?
PP&E Net
73.2m
NOK
Based on the financial report for Dec 31, 2024, Medistim ASA's PP&E Net amounts to 73.2m NOK.
What is Medistim ASA's PP&E Net growth rate?
PP&E Net CAGR 10Y
17%
Over the last year, the PP&E Net growth was 28%. The average annual PP&E Net growth rates for Medistim ASA have been 8% over the past three years , 2% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet